Skip to contentB
BioCorRx Inc.
B
BICXBioCorRx Inc. Q1 2018 · 10-Q
Revenue$147.72K$147.72K+10.1% vs Q1 2017 Net Income-$1.00M-$1.00MN/M vs Q1 2017 EPS Diluted-$0.41-$0.41N/M vs Q1 2017 Operating Income-$538,955N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCorRx Inc. · CIK 1443863 · Engraved from SEC EDGAR
Margins · derivedOperating margin-364.8%−57.6 pt vs Q1 2017
Net margin-678.1%+27882.1 pt vs Q1 2017
ended Mar 31, 2018 · filed May 18, 2018 · 48 d after period end